Search

everythinglearnresearchcommunity

for

Search:↓

A hair-straightening product caused widespread hair loss and scalp injuries, mainly affecting African American women.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

The objective approach for creating search strategies is as effective as the traditional method and might be better and more efficient.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Both intense pulsed light and long-pulsed diode laser effectively reduced facial hair in women, with no significant difference in satisfaction after 6 months, but intense pulsed light was more painful.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Most tinea capitis cases in southern Taiwan were in adult women, mainly caused by Trichophyton violaceum.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The combined therapy was effective and safe for children with severe alopecia areata.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.